CEO Christophe Weber said that the investment is not a new strategy and reflects the position of the U.S. as the world’s leading market for biopharma innovation.
The announcement comes after President Trump signed an executive order aimed at expediting the approval process for domestic pharmaceutical manufacturing facilities.
Expansions at sites in Le Mans and Mourenx, France have solidified the CDMO’s position in targeting the hot antibody-drug conjugate and peptide purification markets.
Dave Ricks said Lilly supports the administration’s goal of bringing pharma manufacturing back to the U.S. but doesn’t see tariffs as the “right mechanism” for reshoring.
CEO Albert Bourla said that President Trump’s threat of pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and R&D.
CEO Rob Michael told analysts that the company is investing more than $10 billion in the U.S. to support volume growth and expansion into new areas such as obesity.
The 700,000-square-foot plant in Holly Springs will create more than 400 jobs and support Roche and Genentech’s future portfolio of next-generation obesity medicines.
Explore how real-time TOC sensors are transforming pharmaceutical water systems by delivering continuous monitoring of organic contaminants, ensuring compliance and safety. With...
Blending and tableting create hazardous dusts. Learn how dust collector filters reduce exposure—download our eBook about media that is best for each dust type.
Pharmaceutical manufacturing hinges on the production of purified water that meets strict pharmacopeia regulations. To ensure consistent water quality, real-time monitoring is...
Take corrective action before a system goes out of specification, ensuring that your processes remain streamlined and compliant. With continuous insights at your fingertips, you...
Regulations in the pharmaceutical industry are constantly increasing— and navigating them doesn’t have to be overwhelming. Discover a real-world example using continuous TOC monitoring...
